Audited Results of Alivus Life Sciences Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	2,551.83	2,386.88	2,283.21	2,161.22	2,123.21
Manufacturing Expenses	119.92	119.67	115.63	118.08	103.57
Personnel Expenses	272.47	251.70	258.16	180.18	168.72
Selling Expenses	0	0	0	0	0
Administrative Expenses	276.24	236.24	217.65	191.80	179.82
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,754.55	1,704.30	1,608.97	1,518.93	1,507.15
Operating Profit	797.28	682.58	674.25	642.29	616.06
Other Recurring Income	60.41	34.57	12.04	28.96	14.70
Adjusted PBDIT	857.70	717.15	686.29	671.25	630.76
Financial Expenses	5.37	2.41	1.55	0.55	27.96
Depreciation	75.36	60.61	53.45	42.09	37.88
Other Write offs	0	0	0	0	0
Adjusted PBT	776.97	654.13	631.29	628.61	564.92
Tax Charges	186.83	168.50	160.40	161.65	146.20
Adjusted PAT	590.14	485.63	470.89	466.96	418.72
Non Recurring Items	-24.43	-1.25	-5.46	-0.29	0.10
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	564.48	485.63	470.89	466.96	418.72
Equity Dividend	61.34	0	275.69	385.96	128.65
Preference Dividend	0	0	0	0	0
Retained Earnings	2,281.55	1,776.18	1,291.80	1,102.06	1,040.95

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article